Frank Halling
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Frank Halling has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
H.-A. Merten
5 shared publications- Andreas Neff
Department of Oral and Craniomaxillofacial Surgery, UKGM GmbH, University Hospital Marburg and Faculty of Medicine, Philipps University, 35043 Marburg, Germany
4 shared publications Andreas Neff
Professor, Department of Maxillofacial Surgery, University Hospital, Marburg, Germany
3 shared publicationsH A Merten
3 shared publicationsThomas Ziebart
Assistant Professor, Department of Maxillofacial Surgery, University Hospital, Marburg, Germany
3 shared publications- Andreas Pabst
Klinik für Mund‑, Kiefer- und plastische Gesichtschirurgie, Bundeswehrzentralkrankenhaus, Koblenz, Deutschland
2 shared publications
Latest Publications
- Open Access
- 2 February 2026
- Published by MDPI AG in Dentistry Journal
- Vol. 14 (2) , 83
Oral Side Effects of the Most Commonly Prescribed Drugs in Germany
Background: The aim of this study is to investigate the potential link between the use of specific medications and oral adverse drug reactions. Methods: The 100 most frequently prescribed drugs in Germany in 2023 were compiled using the “PharMaAnalyst” database. According to the descriptions of adverse drug reactions (ADRs) in the patient information leaflets the ADRs were selected, analyzed and weighted with scores according to a classification system that distinguishes four groups of ADRs by frequency: ‘very common’ (4), ‘common’ (3), ‘uncommon’ (2) and ‘rare’ (1). The objective was to summarize the scores of the oral ADRs and define the ‘oral side effect score’ (OSES). Results: After accounting for duplication due to various brand names, 49 medications were reviewed. A total of 65% of the medications exhibited oral ADRs. The number of oral ADRs per medication ranged from one to seven. Xerostomia and dysgeusia were the most prevalent oral side effects, accounting for 37% of cases. Overall, 34% of side effects were classified as either ‘very common’ or ‘common’. The medication groups with the highest OSES were antidepressants, antibiotics and analgesics. Of the individual medications, azithromycin, gabapentin and pregabalin exhibited the highest OSES. Conclusions: This study provides a comprehensive overview of oral side effects associated with the 100 most frequently prescribed drugs. Patients with polypharmacy are particularly likely to experience oral side effects such as xerostomia and dysgeusia. Due to their high OSES combinations, antibiotics, analgesics or antidepressants may trigger multiple oral ADRs. It is essential that the medical community is continuously updated on pharmacological knowledge to raise awareness of oral ADRs.
- 2 February 2026
- Published by MDPI AG in Dentistry Journal
- Vol. 14 (2) , 83
Open AccessOral Side Effects of the Most Commonly Prescribed Drugs in Germany
Background: The aim of this study is to investigate the potential link between the use of specific medications and oral adverse drug reactions. Methods: The 100 most frequently prescribed drugs in Germany in 2023 were compiled using the “PharMaAnalyst” database. According to the descriptions of adverse drug reactions (ADRs) in the patient information leaflets the ADRs were selected, analyzed and weighted with scores according to a classification system that distinguishes four groups of ADRs by frequency: ‘very common’ (4), ‘common’ (3), ‘uncommon’ (2) and ‘rare’ (1). The objective was to summarize the scores of the oral ADRs and define the ‘oral side effect score’ (OSES). Results: After accounting for duplication due to various brand names, 49 medications were reviewed. A total of 65% of the medications exhibited oral ADRs. The number of oral ADRs per medication ranged from one to seven. Xerostomia and dysgeusia were the most prevalent oral side effects, accounting for 37% of cases. Overall, 34% of side effects were classified as either ‘very common’ or ‘common’. The medication groups with the highest OSES were antidepressants, antibiotics and analgesics. Of the individual medications, azithromycin, gabapentin and pregabalin exhibited the highest OSES. Conclusions: This study provides a comprehensive overview of oral side effects associated with the 100 most frequently prescribed drugs. Patients with polypharmacy are particularly likely to experience oral side effects such as xerostomia and dysgeusia. Due to their high OSES combinations, antibiotics, analgesics or antidepressants may trigger multiple oral ADRs. It is essential that the medical community is continuously updated on pharmacological knowledge to raise awareness of oral ADRs.
- 2 September 2025
- Published by Springer Nature in Die MKG-Chirurgie
- Vol. 18 (3) , 218-225
Penicillinallergie: eine medizinische Herausforderung
- 2 September 2025
- Published by Springer Nature in Die MKG-Chirurgie
- Vol. 18 (3) , 218-225
Penicillinallergie: eine medizinische Herausforderung
- Open Access
- 22 April 2025
- Published by MDPI AG in Dentistry Journal
- Vol. 13 (5) , 180
True Allergies to Articaine: A 25-Year Analysis
Background: Although allergic reactions to amide local anesthetics (LA) are rare, it is important for medical professionals to be aware of their potential occurrence. Despite the fact that articaine is one of the most commonly used LA in dentistry, a survey of documented cases of allergies to articaine is absent from the literature. The objective of this review was to ascertain how often true allergies to articaine, verified by standard allergological procedures, have been reported over the last 25 years. Methods: A comprehensive review of the literature from 1 January 2000 to 31 December 2024 was conducted using the PubMed-MEDLINE database. The search was limited to articles investigating suspected allergy to articaine. The search strategy encompassed indexing terms, keywords, and free-text words, complemented by an extensive manual search. The final determination was based on the application of skin and/or challenge tests as the gold standard for identifying articaine as the causative agent. Results: During the investigation period, 10 case reports and six case series, encompassing 29 patients with a confirmed true allergy to articaine, were identified. The age of the patients ranged from 8 to 65 years, with a median age of 34 years. Of these patients, 20 were diagnosed with an immediate type I allergy, while 5 patients exhibited a delayed type IV allergy. In four cases the specific type of allergy was not mentioned. In the majority of cases an intradermal test (IDT) was employed to ascertain the specific type of allergy. Cross-reactivity with other amide LA was reported in three cases. Conclusions: True allergies to articaine are exceedingly rare. Investigation strategies should include a combination of a thorough clinical history and a standardized allergological procedure entailing skin tests and challenge. Only a comprehensive approach ensures the accurate identification of affected patients and facilitates the selection of a tolerated LA.
- 22 April 2025
- Published by MDPI AG in Dentistry Journal
- Vol. 13 (5) , 180
Open AccessTrue Allergies to Articaine: A 25-Year Analysis
Background: Although allergic reactions to amide local anesthetics (LA) are rare, it is important for medical professionals to be aware of their potential occurrence. Despite the fact that articaine is one of the most commonly used LA in dentistry, a survey of documented cases of allergies to articaine is absent from the literature. The objective of this review was to ascertain how often true allergies to articaine, verified by standard allergological procedures, have been reported over the last 25 years. Methods: A comprehensive review of the literature from 1 January 2000 to 31 December 2024 was conducted using the PubMed-MEDLINE database. The search was limited to articles investigating suspected allergy to articaine. The search strategy encompassed indexing terms, keywords, and free-text words, complemented by an extensive manual search. The final determination was based on the application of skin and/or challenge tests as the gold standard for identifying articaine as the causative agent. Results: During the investigation period, 10 case reports and six case series, encompassing 29 patients with a confirmed true allergy to articaine, were identified. The age of the patients ranged from 8 to 65 years, with a median age of 34 years. Of these patients, 20 were diagnosed with an immediate type I allergy, while 5 patients exhibited a delayed type IV allergy. In four cases the specific type of allergy was not mentioned. In the majority of cases an intradermal test (IDT) was employed to ascertain the specific type of allergy. Cross-reactivity with other amide LA was reported in three cases. Conclusions: True allergies to articaine are exceedingly rare. Investigation strategies should include a combination of a thorough clinical history and a standardized allergological procedure entailing skin tests and challenge. Only a comprehensive approach ensures the accurate identification of affected patients and facilitates the selection of a tolerated LA.
- 9 April 2024
- Published by Springer Nature in Die MKG-Chirurgie
- Vol. 17 (2) , 91-99
Der Einfluss von Arzneimitteln auf die Mundschleimhaut
- 9 April 2024
- Published by Springer Nature in Die MKG-Chirurgie
- Vol. 17 (2) , 91-99
Der Einfluss von Arzneimitteln auf die Mundschleimhaut
- Open Access
- 17 January 2024
- Published by Springer Nature in Clinical Oral Investigations
- Vol. 28 (1) , 1-10
Facts and trends in dental antibiotic and analgesic prescriptions in Germany, 2012–2021
Objectives: The study aims to overview German dentists’ development of antibiotic and analgesic prescriptions from 2012 to 2021. Materials and methods: A longitudinal database analysis was performed based on the annual reports of the “Research Institute for Local Health Care Systems” (WIdO, Berlin). Results: From 2012 until 2021, dental antibiotic prescriptions fell by 17.9%. In contrast, the dental proportion of antibiotic prescriptions compared to all antibiotic prescriptions in Germany increased from 9.1 to 13.6%. Aminopenicillins enhanced their share from 35.6 to 49.4%, while clindamycin prescriptions declined from 37.8 to 23.4%. The proportion of ibuprofen prescriptions significantly increased from 60.4% in 2012 to 79.0% in 2021. Conclusions: Since 2013, the most frequently prescribed antibiotic by German dentists has been amoxicillin reaching nearly half of all dental antibiotic prescriptions in 2021. Simultaneously, the proportion of clindamycin has steadily decreased, but the level is still high compared to international data. During the past decade, ibuprofen as a first-line analgesic in German dentistry was continuously gaining in importance. Clinical relevance: Aminopenicillins have the best risk–benefit balance in dentistry, but the use of antibiotics generally must be limited only to cases of severe infections or compromised patients. Pre-existing diseases or permanent medications should always be considered when choosing an analgesic.
- 17 January 2024
- Published by Springer Nature in Clinical Oral Investigations
- Vol. 28 (1) , 1-10
Open AccessFacts and trends in dental antibiotic and analgesic prescriptions in Germany, 2012–2021
Objectives: The study aims to overview German dentists’ development of antibiotic and analgesic prescriptions from 2012 to 2021. Materials and methods: A longitudinal database analysis was performed based on the annual reports of the “Research Institute for Local Health Care Systems” (WIdO, Berlin). Results: From 2012 until 2021, dental antibiotic prescriptions fell by 17.9%. In contrast, the dental proportion of antibiotic prescriptions compared to all antibiotic prescriptions in Germany increased from 9.1 to 13.6%. Aminopenicillins enhanced their share from 35.6 to 49.4%, while clindamycin prescriptions declined from 37.8 to 23.4%. The proportion of ibuprofen prescriptions significantly increased from 60.4% in 2012 to 79.0% in 2021. Conclusions: Since 2013, the most frequently prescribed antibiotic by German dentists has been amoxicillin reaching nearly half of all dental antibiotic prescriptions in 2021. Simultaneously, the proportion of clindamycin has steadily decreased, but the level is still high compared to international data. During the past decade, ibuprofen as a first-line analgesic in German dentistry was continuously gaining in importance. Clinical relevance: Aminopenicillins have the best risk–benefit balance in dentistry, but the use of antibiotics generally must be limited only to cases of severe infections or compromised patients. Pre-existing diseases or permanent medications should always be considered when choosing an analgesic.
- Open Access
- 1 January 2024
- Published by XMLink in Journal of Periodontal & Implant Science
- Vol. 54 (3) , 139-148
A large animal model of periodontal defects in bisphosphonate-related osteonecrosis of the jaw: a comparison of clinical and radiological findings
Otto M, et al. J Periodontal Implant Sci. 2023 Jul;53:e43. https://doi.org/10.5051/jpis.2204860243
- 1 January 2024
- Published by XMLink in Journal of Periodontal & Implant Science
- Vol. 54 (3) , 139-148
Open AccessA large animal model of periodontal defects in bisphosphonate-related osteonecrosis of the jaw: a comparison of clinical and radiological findings
Otto M, et al. J Periodontal Implant Sci. 2023 Jul;53:e43. https://doi.org/10.5051/jpis.2204860243
- 1 October 2022
- Published by Georg Thieme Verlag KG in Zahnmedizin up2date
- Vol. 16 (05) , 441-455
Unerwünschte Arzneimittelwirkungen und Interaktionen wichtiger zahnärztlicher Wirkstoffe
Die zahnärztliche Arzneimitteltherapie wird durch 3 Medikamentengruppen bestimmt: Antibiotika, Analgetika und Lokalanästhetika. Obwohl in der Zahnmedizin nur relativ wenige Wirkstoffgruppen angewendet werden, sind unerwünschte Arzneimittelwirkungen, Wechselwirkungen und Interaktionen mit anderen Medikamenten möglich und durchaus komplex. Vor allem geriatrische und multimorbide Patienten mit umfangreicher Dauermedikation stellen für jede zahnärztliche Praxis eine pharmakotherapeutische Herausforderung dar. Da diese Patientengruppe aufgrund des demografischen Wandels deutlich zunehmen wird, ist eine ständige Aktualisierung pharmakologischer Zusammenhänge auch in der Zahnmedizin unabdingbar. Article published online: 18 November 2022 © 2022. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 1 October 2022
- Published by Georg Thieme Verlag KG in Zahnmedizin up2date
- Vol. 16 (05) , 441-455
Unerwünschte Arzneimittelwirkungen und Interaktionen wichtiger zahnärztlicher Wirkstoffe
Die zahnärztliche Arzneimitteltherapie wird durch 3 Medikamentengruppen bestimmt: Antibiotika, Analgetika und Lokalanästhetika. Obwohl in der Zahnmedizin nur relativ wenige Wirkstoffgruppen angewendet werden, sind unerwünschte Arzneimittelwirkungen, Wechselwirkungen und Interaktionen mit anderen Medikamenten möglich und durchaus komplex. Vor allem geriatrische und multimorbide Patienten mit umfangreicher Dauermedikation stellen für jede zahnärztliche Praxis eine pharmakotherapeutische Herausforderung dar. Da diese Patientengruppe aufgrund des demografischen Wandels deutlich zunehmen wird, ist eine ständige Aktualisierung pharmakologischer Zusammenhänge auch in der Zahnmedizin unabdingbar. Article published online: 18 November 2022 © 2022. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 26 April 2022
- Published by Elsevier in British Journal of Oral and Maxillofacial Surgery
- Vol. 60 (8) , 1097-1101
Medical status of elderly patients consulting two oral and maxillofacial surgery departments in Germany
- 26 April 2022
- Published by Elsevier in British Journal of Oral and Maxillofacial Surgery
- Vol. 60 (8) , 1097-1101
Medical status of elderly patients consulting two oral and maxillofacial surgery departments in Germany
- 1 January 2021
- Published by American Dental Society of Anesthesiology (ADSA) in Anesthesia Progress
- Vol. 68 (1) , 19-25
Local Anesthetic Usage Among Dentists: German and International Data
The aim of this study was to analyze the use of dental local anesthetics in Germany compared with international data. The type and distribution of dental local anesthetics and added vasoconstrictors based on a representative sample of German dentists itemized over a period of 7 years (2011 to 2017) were evaluated and statistically analyzed. The results were compared with international dental local anesthetic consumption data published since 2005. With a consistent market share of nearly 98%, articaine was the first-line local dental anesthetic agent in Germany. During the investigation period, German dental local anesthetics with epinephrine 1:200,000 had ∼50% market shares, whereas formulations with epinephrine 1:100,000 had 40% to 45% market shares. Articaine, with market shares between 38% and 81%, was also the preferred anesthetic agent in various other countries, with the notable exceptions of the United Kingdom and the United States, where lidocaine was the preferred local anesthetic agent. Epinephrine was the preferred vasoconstrictor internationally, similar to Germany. The larger market share of higher concentrated epinephrine 1:100,000 was remarkable, considering the increasing number of medically compromised patients. Increased consideration for using agents with reduced dosages of epinephrine (1:200,000) is generally recommended.
- 1 January 2021
- Published by American Dental Society of Anesthesiology (ADSA) in Anesthesia Progress
- Vol. 68 (1) , 19-25
Local Anesthetic Usage Among Dentists: German and International Data
The aim of this study was to analyze the use of dental local anesthetics in Germany compared with international data. The type and distribution of dental local anesthetics and added vasoconstrictors based on a representative sample of German dentists itemized over a period of 7 years (2011 to 2017) were evaluated and statistically analyzed. The results were compared with international dental local anesthetic consumption data published since 2005. With a consistent market share of nearly 98%, articaine was the first-line local dental anesthetic agent in Germany. During the investigation period, German dental local anesthetics with epinephrine 1:200,000 had ∼50% market shares, whereas formulations with epinephrine 1:100,000 had 40% to 45% market shares. Articaine, with market shares between 38% and 81%, was also the preferred anesthetic agent in various other countries, with the notable exceptions of the United Kingdom and the United States, where lidocaine was the preferred local anesthetic agent. Epinephrine was the preferred vasoconstrictor internationally, similar to Germany. The larger market share of higher concentrated epinephrine 1:100,000 was remarkable, considering the increasing number of medically compromised patients. Increased consideration for using agents with reduced dosages of epinephrine (1:200,000) is generally recommended.